Frequency Specific Microcurrent for Osteoarthritis

N/A

Waitlist Available

Led By Samuel Spaiser, MS

Research Sponsored by Nova Southeastern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

active osteoarthritis diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, and immediately after the intervention

Summary

"This trial aims to test if using a specific type of microcurrent can reduce inflammation in osteoarthritis patients, leading to less pain and potentially slowing down the disease. Participants will undergo one hour of

Who is the study for?

This trial is for adults over 18 with a BMI greater than 29.9 who have been actively diagnosed with osteoarthritis. It's not specified, but typically people are excluded if they have conditions that might interfere with the treatment or skew results.

What is being tested?

The study is testing Frequency Specific Microcurrent (FSM) to see if it reduces inflammation and pain in osteoarthritis patients compared to a sham (fake) treatment. Participants will undergo an hour of FSM and complete questionnaires about their pain before and after treatment.

What are the potential side effects?

While specific side effects aren't listed, microcurrent treatments are generally considered safe but may include mild discomfort or skin irritation at the site of application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with active osteoarthritis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, during the intervention (15 minutes, 30 minutes, 45 minutes), and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Interleukin-6

Secondary study objectives

General Pain

Tumor Necrosis Factor Alpha

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: FSM Treatment GroupExperimental Treatment1 Intervention

Participants receiving the 40 hertz/97 hertz alternating sharp square wave 200 uamp microcurrent treatment (machine is turned on and placed in an opaque bag to cover the screen; the machine is silent and therefore will be indistinguishable form placebo)

Group II: Placebo Group (Sham)Placebo Group1 Intervention

Participants receiving sham microcurrent treatment (machine is turned off and placed in an opaque bag to cover the screen)

0 / 2Eligibility criteria met